Lv31
350 积分 2023-09-18 加入
Oxyntomodulin: Actions and role in diabetes
5小时前
待确认
Glycemic Trends in Patients with Thyroid Eye Disease Treated with Teprotumumab in 3 Clinical Trials
13天前
已完结
Tirzepatide for Weight Reduction in Chinese Adults With Obesity
13天前
已完结
Glucagon: The renewal of an old hormone in the pathophysiology of diabetes (胰升糖素：一种老激素在糖尿病病理生理中的新作用)
21天前
已完结
Inhibition of the glucose transporter SGLT2 with dapagliflozin in pancreatic alpha cells triggers glucagon secretion
21天前
已完结
Glucagon revisited: Coordinated actions on the liver and kidney
23天前
已完结
Reduced insulin signaling and high glucagon in early insulin resistance impaired fast‐fed regulation of renal gluconeogenesis via insulin receptor substrate
25天前
已完结
Recurrent Thyroid Eye Disease
29天前
已完结
Proptosis Regression After Teprotumumab Treatment for Thyroid Eye Disease
1个月前
已完结
A novel dual glucagon‐like peptide and glucagon receptor agonist SAR425899: Results of randomized, placebo‐controlled first‐in‐human and first‐in‐patient trials
1个月前
已完结
皖公网安备34019202002308
